Exact Mass: 481.19612420000004

Exact Mass Matches: 481.19612420000004

Found 500 metabolites which its exact mass value is equals to given mass value 481.19612420000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pranlukast

C27H23N5O4 (481.17499580000003)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

Pranlukast

N-[4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-7-yl]-4-(4-phenylbutoxy)benzamide

C27H23N5O4 (481.17499580000003)

Pranlukast is only found in individuals that have used or taken this drug. It is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.Pranlukast selectively antagonizes leukotriene D₄ (LTD₄) at the cysteinyl leukotriene receptor, CysLT₁, in the human airway. Pranlukast inhibits the actions of LTD₄ at the CysLT₁ receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.

Acebilustat

4-[[5-[[4-[4-(1,3-Oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid

C29H27N3O4 (481.20014620000006)

Stallimycin

1H-Pyrrole-2-carboxamide,N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-(formylamino)-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-

C22H27N9O4 (481.21859020000005)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

gamma-Glutamyl-N'-(2-hydroxyphenyl)hydrazide

4-Amino-5-{4-hydroxy-3-[4-(2-hydroxyphenyl)tetraazan-1-yl]phenyl}-N-(2-hydroxyphenyl)-5-oxopentanehydrazonate

C23H27N7O5 (481.20735720000005)

1,3-Dithiane-2-propanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-2-(2-naphthalenyl)-

[2-(3,4-dimethoxyphenyl)ethyl](methyl){3-[2-(naphthalen-2-yl)-1,3-dithian-2-yl]propyl}amine

C28H35NO2S2 (481.210909)

(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]-6-fluoro-4,5-dioxohexanoic acid

C22H28FN3O8 (481.186034)

Benzyloxycarbonylvalyl-alanyl-aspartyl Fluoromethyl Ketone

3-({2-[(2-{[(benzyloxy)(hydroxy)methylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxypropylidene}amino)-6-fluoro-4,5-dioxohexanoate

C22H28FN3O8 (481.186034)

Ala Asp Asn Tyr

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C20H27N5O9 (481.1808692000001)

Ala Asp Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C20H27N5O9 (481.1808692000001)

Ala Phe Met Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C21H31N5O6S (481.19949460000004)

Ala Phe Asn Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C21H31N5O6S (481.19949460000004)

Ala Met Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C21H31N5O6S (481.19949460000004)

Ala Met Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C21H31N5O6S (481.19949460000004)

Ala Asn Asp Tyr

(3S)-3-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C20H27N5O9 (481.1808692000001)

Ala Asn Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C21H31N5O6S (481.19949460000004)

Ala Asn Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C21H31N5O6S (481.19949460000004)

Ala Asn Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C20H27N5O9 (481.1808692000001)

Ala Gln Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid